JP2001512666A5 - - Google Patents

Download PDF

Info

Publication number
JP2001512666A5
JP2001512666A5 JP2000506228A JP2000506228A JP2001512666A5 JP 2001512666 A5 JP2001512666 A5 JP 2001512666A5 JP 2000506228 A JP2000506228 A JP 2000506228A JP 2000506228 A JP2000506228 A JP 2000506228A JP 2001512666 A5 JP2001512666 A5 JP 2001512666A5
Authority
JP
Japan
Prior art keywords
crca
sequence
functional fragment
unique
transcript
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000506228A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001512666A (ja
JP4456266B2 (ja
Filing date
Publication date
Priority claimed from US08/908,643 external-priority patent/US6120995A/en
Application filed filed Critical
Publication of JP2001512666A publication Critical patent/JP2001512666A/ja
Publication of JP2001512666A5 publication Critical patent/JP2001512666A5/ja
Application granted granted Critical
Publication of JP4456266B2 publication Critical patent/JP4456266B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000506228A 1997-08-07 1998-08-07 結腸直腸癌細胞に特異的に結合する組成物およびその使用法 Expired - Fee Related JP4456266B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/908,643 1997-08-07
US08/908,643 US6120995A (en) 1997-08-07 1997-08-07 Compositions that specifically bind to colorectal cancer cells and methods of using the same
PCT/US1998/016440 WO1999007726A1 (en) 1997-08-07 1998-08-07 Compositions that specifically bind to colorectal cancer cells and methods of using the same

Publications (3)

Publication Number Publication Date
JP2001512666A JP2001512666A (ja) 2001-08-28
JP2001512666A5 true JP2001512666A5 (https=) 2009-05-28
JP4456266B2 JP4456266B2 (ja) 2010-04-28

Family

ID=25426064

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000506228A Expired - Fee Related JP4456266B2 (ja) 1997-08-07 1998-08-07 結腸直腸癌細胞に特異的に結合する組成物およびその使用法

Country Status (6)

Country Link
US (1) US6120995A (https=)
EP (1) EP1003769A4 (https=)
JP (1) JP4456266B2 (https=)
AU (1) AU738504B2 (https=)
CA (1) CA2299630C (https=)
WO (1) WO1999007726A1 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234615A (en) * 1987-10-02 1993-08-10 Ecolab Inc. Article comprising a water soluble bag containing a multiple use amount of a pelletized functional material and methods of its use
US7135333B1 (en) * 1997-08-07 2006-11-14 Thomas Jefferson University Compositions that specifically bind to colorectal cancer cells and methods of using the same
ATE510855T1 (de) * 2000-03-06 2011-06-15 Univ Kentucky Res Found Verwendung eines antikörpers oder eines immunotoxins, der bzw. das selektiv an cd123 bindet zur beeinträchtigung hämatologischer krebs-vorläuferzellen
AU2001249548A1 (en) * 2000-03-27 2001-10-08 Thomas Jefferson University Compositions and methods for identifying and targeting cancer cells
DE60136632D1 (de) * 2000-06-21 2009-01-02 Lantheus Medical Imaging Inc Vitronectin rezeptor antagonist pharmaka
US7829276B2 (en) * 2000-09-18 2010-11-09 Thomas Jefferson University Methods of using CRCA-1 as a stomach and esophageal cancer marker
US20030170756A1 (en) * 2002-02-01 2003-09-11 Thomas Jefferson University Treatment of tumor cells for use in immunotherapy of cancer
US20030232013A1 (en) * 2002-02-22 2003-12-18 Gary Sieckman Therapeutic and diagnostic targeting of cancers cells with tumor homing peptides
US8435529B2 (en) 2002-06-14 2013-05-07 Immunomedics, Inc. Combining radioimmunotherapy and antibody-drug conjugates for improved cancer therapy
US7282567B2 (en) * 2002-06-14 2007-10-16 Immunomedics, Inc. Monoclonal antibody hPAM4
US9238081B2 (en) * 2002-06-14 2016-01-19 Immunomedics, Inc. Detection of early-stage pancreatic adenocarcinoma
US8574854B2 (en) 2002-06-14 2013-11-05 Immunomedics, Inc. Anti-mucin antibodies for early detection and treatment of pancreatic cancer
US20040018494A1 (en) * 2002-07-25 2004-01-29 Shurtliff Roxanne N Isothermal transcription based amplification assay for detection and quantification of guanylyl cyclase C
US20050074793A1 (en) * 2003-04-04 2005-04-07 Wilson Keith E. Metastatic colorectal cancer signatures
US9005613B2 (en) 2003-06-16 2015-04-14 Immunomedics, Inc. Anti-mucin antibodies for early detection and treatment of pancreatic cancer
US20080038686A1 (en) * 2006-04-18 2008-02-14 Shigemi Nagai Methods and kits for early stage caries detection
WO2008127735A1 (en) 2007-04-13 2008-10-23 Stemline Therapeutics, Inc. Il3ralpha antibody conjugates and uses thereof
WO2009140436A2 (en) * 2008-05-13 2009-11-19 Thomas Jefferson University Guanylyl cyclase c qrt-pcr
JP2012518389A (ja) 2009-02-25 2012-08-16 ダイアグノキュア インコーポレイテッド Ｇｉ癌の転移を検出するための方法
MY173390A (en) * 2009-10-23 2020-01-22 Takeda Pharmaceuticals Co Anti-gcc antibody molecules and related compositions and methods
ME03560B (me) 2012-04-27 2020-07-20 Millennium Pharm Inc MOLEKULI ANTI-GCC ANTITELA l NJIHOVA UPOTREBA U ISPITIVANJU OSETLJIVOSTI NA GCC-CILJANU TERAPIJU
US9382329B2 (en) 2012-08-14 2016-07-05 Ibc Pharmaceuticals, Inc. Disease therapy by inducing immune response to Trop-2 expressing cells
US9452228B2 (en) 2013-04-01 2016-09-27 Immunomedics, Inc. Antibodies reactive with an epitope located in the N-terminal region of MUC5AC comprising cysteine-rich subdomain 2 (Cys2)
JP2014158468A (ja) * 2014-03-05 2014-09-04 Clinical Genomics Pty Ltd 検出方法

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4375414A (en) * 1971-05-20 1983-03-01 Meir Strahilevitz Immunological methods for removing species from the blood circulatory system and devices therefor
US4022878A (en) * 1972-05-15 1977-05-10 Biological Developments, Inc. Methods and compounds for producing specific antibodies
US4526716A (en) * 1981-11-20 1985-07-02 The Ohio State University Antigenic modification of polypeptides
US4329281A (en) * 1978-06-05 1982-05-11 Hoffmann-La Roche Inc. Hapten compositions
US4873191A (en) * 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
US4584268A (en) * 1981-10-13 1986-04-22 Ceriani Roberto Luis Method and compositions for carcinoma diagnosis
US4601896A (en) * 1984-03-21 1986-07-22 Mark Nugent Pharmaceutical capsule compositions and structures for gastric sensitive materials
US4736866B1 (en) * 1984-06-22 1988-04-12 Transgenic non-human mammals
US4945050A (en) * 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US4729893A (en) * 1984-12-26 1988-03-08 Robert L. Letcher Enteric encapsulation of ancrod for oral administration
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4965188A (en) * 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
GB8508845D0 (en) * 1985-04-04 1985-05-09 Hoffmann La Roche Vaccinia dna
US5160723A (en) * 1985-04-19 1992-11-03 Sloan-Kettering Institute For Cancer Research Method of imaging colorectal carcinoma lesion and composition for use therein
JPS62162963A (ja) * 1986-01-10 1987-07-18 Sadao Shiosaka 金属コロイド粒子を担体とする低分子物質に対する特異抗体の作成法
US4849227A (en) * 1986-03-21 1989-07-18 Eurasiam Laboratories, Inc. Pharmaceutical compositions
US5399347A (en) * 1987-06-24 1995-03-21 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen
US4963263A (en) * 1988-03-24 1990-10-16 Terrapin Technologies, Inc. Method of identity analyte-binding peptides
US5133866A (en) * 1988-03-24 1992-07-28 Terrapin Technologies, Inc. Method to identify analyte-bending ligands
US5217869A (en) * 1987-10-13 1993-06-08 Terrapin Technologies, Inc. Method to produce immunodiagnostic reagents
US5340474A (en) * 1988-03-24 1994-08-23 Terrapin Technologies, Inc. Panels of analyte-binding ligands
US5350741A (en) * 1988-07-30 1994-09-27 Kanji Takada Enteric formulations of physiologically active peptides and proteins
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5075216A (en) * 1988-09-23 1991-12-24 Cetus Corporation Methods for dna sequencing with thermus aquaticus dna polymerase
US5049656A (en) * 1988-12-21 1991-09-17 Board Of Regents Of The University Of Nebraska Sequential peptide and oligonucleotide syntheses using immunoaffinity techniques
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5424186A (en) * 1989-06-07 1995-06-13 Affymax Technologies N.V. Very large scale immobilized polymer synthesis
US5271961A (en) * 1989-11-06 1993-12-21 Alkermes Controlled Therapeutics, Inc. Method for producing protein microspheres
US5252743A (en) * 1989-11-13 1993-10-12 Affymax Technologies N.V. Spatially-addressable immobilization of anti-ligands on surfaces
US5366862A (en) * 1990-02-14 1994-11-22 Receptor Laboratories, Inc. Method for generating and screening useful peptides
CA2039517C (en) * 1990-04-03 2006-11-07 David Segev Dna probe signal amplification
US5430138A (en) * 1990-07-27 1995-07-04 Chiron Corporation Hydroxyl-protecting groups attached to cytidine nucleotide compounds which are orthogonally removable
US5237051A (en) * 1990-12-06 1993-08-17 Vanderbilt University Purified enterotoxin receptor protein
US5352775A (en) * 1991-01-16 1994-10-04 The Johns Hopkins Univ. APC gene and nucleic acid probes derived therefrom
US5330892A (en) * 1991-03-13 1994-07-19 The Johns Hopkins University MCC gene (mutated in colorectal cancer) used for diagnosis of cancer in humans
US5270170A (en) * 1991-10-16 1993-12-14 Affymax Technologies N.V. Peptide library and screening method
US5384261A (en) * 1991-11-22 1995-01-24 Affymax Technologies N.V. Very large scale immobilized polymer synthesis using mechanically directed flow paths
US5412087A (en) * 1992-04-24 1995-05-02 Affymax Technologies N.V. Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces
US5395750A (en) * 1992-02-28 1995-03-07 Hoffmann-La Roche Inc. Methods for producing proteins which bind to predetermined antigens
US5420328A (en) * 1992-09-11 1995-05-30 Affymax Technologies, N.V. Methods for the synthesis of phosphonate esters
US5288514A (en) * 1992-09-14 1994-02-22 The Regents Of The University Of California Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
US5324483B1 (en) * 1992-10-08 1996-09-24 Warner Lambert Co Apparatus for multiple simultaneous synthesis
US5518888A (en) * 1993-10-26 1996-05-21 Thomas Jefferson University ST receptor binding compounds and methods of using the same
EP0734264B1 (en) * 1993-10-26 2004-02-18 Thomas Jefferson University Compositions that specifically bind to colorectal cancer cells and methods of using the same
US5601990A (en) * 1994-09-13 1997-02-11 Thomas Jefferson University Methods of diagnosing colorectal tumors and metastasis thereof
US5597909A (en) * 1994-08-25 1997-01-28 Chiron Corporation Polynucleotide reagents containing modified deoxyribose moieties, and associated methods of synthesis and use
WO1997042506A1 (en) * 1996-05-03 1997-11-13 Thomas Jefferson University Methods of and kits and compositions for diagnosing colorectal tumors and metastasis thereof

Similar Documents

Publication Publication Date Title
JP2001512666A5 (https=)
Ray et al. Peptide nucleic acid (PNA): its medical and biotechnical applications and promise for the future
Hecker et al. Error analysis of chemically synthesized polynucleotides
JP2004511201A5 (https=)
Siegal et al. A 5'to 3'exonuclease functionally interacts with calf DNA polymerase epsilon.
JP2001514013A5 (https=)
JP2002272489A5 (https=)
Quartin et al. Number and distribution of methyiphosphonate linkages in oligodeoxynucleotides affect exo-and endonuclease sensitivity and ability to form RNase H substrates
JP2003522514A5 (https=)
JP2002531053A5 (https=)
JP2002510465A (ja) 修飾核酸プローブおよびその使用
BRPI0609031A2 (pt) métodos para a sìntese de uma molécula de ácido nucleico, para seletivamente amplificar uma seqüência de ácido nucleico alvo de um dna ou de uma mistura de ácidos nucleicos, para amplificar duas ou mais seqüências de nucleotìdeos alvo simultaneamente, para seqüenciar uma molécula de ácido nucleico alvo, para detectar uma molécula de ácido nucleico com diversidade genética, para detectar uma seqüência de nucleotìdeos alvo em uma amostra da ácido nucléico, e para permitir que uma especifidade anelar de um oligonucleotìdeo seja dualmente determinada por meio de uma estrutura do oligonucleotìdeo, e, oligonucleotìdeo de especifidade dual
JP2003533986A5 (https=)
Sugimoto et al. Stabilization factors affecting duplex formation of peptide nucleic acid with DNA
JP2005525128A5 (https=)
JP3662027B2 (ja) キメラオリゴヌクレオチド及びアンチセンス結合部位の確認におけるそれらの使用
TWI316964B (https=)
Barabino et al. Antisense probes targeted to an internal domain in U2 snRNP specifically inhibit the second step of pre-mRNA splicing
Koziołkiewicz et al. Effect of P‐chirality of oligo (deoxyribonucleoside phosphorothioate) s on the activity of terminal deoxyribonucleotidyl transferase
Trueba et al. Random primed gene walking PCR: a simple procedure to retrieve nucleotide fragments adjacent to known DNA sequences
Kolpashchikov et al. Synthesis of base-substituted dUTP analogues carrying a photoreactive group and their application to study human replication protein A
EP0837950A1 (en) Primer walking cycle sequencing
JP2006514546A5 (https=)
JP2004500045A5 (https=)
JP2000201677A5 (https=)